Restoring Nerve Function
Solaxa is a clinical-stage biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.
We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.
Our Company: By The Numbers
10
Different ataxias have shown treatment response with drug
250+
Ataxia patients studied with drug
13
6 issued and 7 pending US, EU, Canada patents exclusively licensed
20+
Peer-reviewed publications by co-founders
$19M
Non-dilutive NIH & DoD grants to co-founders and clinical trial partners